A. López-Alfonso

Clinical outcomes of FOLFIRINOX and gemcitabine–nab paclitaxel for metastatic pancreatic cancer in the real world setting

A. Royuela, A. Ruiz-Casado, F. Franco, 2020, Clinical and Translational Oncology.

Bilateral inflammatory metachronic ERBB2 (HER2/neu)-positive breast carcinoma: prolonged survival with combined chemotherapy and trastuzumab

A. López-Alfonso, J. Cassinello, A. Lázaro, 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid

P. Gullón, C. Pangua, B. Obispo, 2020, Clinical and Translational Oncology.

Cancer-associated fibroblast-derived gene signatures determine prognosis in colon cancer patients

A. Carrato, M. Herrera, C. Peña, 2021, Molecular Cancer.

Different exosome cargo from plasma/bronchoalveolar lavage in non‐small‐cell lung cancer

M. Provencio, J. García, Javier Silva, 2014, Genes, chromosomes & cancer.

Covid-19 and lung cancer: A greater fatality rate?

P. Gullón, C. Pangua, B. Obispo, 2020, Lung Cancer.

A Multicenter Analysis of the Outcome of Cancer Patients with Neutropenia and COVID-19 Optionally Treated with Granulocyte-Colony Stimulating Factor (G-CSF): A Comparative Analysis

Gonzalo Colmenarejo, A. Collazo-Lorduy, E. Casado, 2021, Cancers.

Axitinib treatment in advanced RAI-resistant differentiated thyroid cancer (DTC) and refractory medullary thyroid cancer (MTC).

I. Matos, J. Capdevila, E. Grande, 2017, European journal of endocrinology.